Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR) TRADING HALT SUSPENDED

20mins delayed


1 Year Return

Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB Chart

Share price
Market Cap $84.67 million
Today's Movement
Prev. Close
Day Range -
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover

IMR Statistics

23 January

891 / 2,294

ASX Size Rank

1yr Return

vs Sector (1yr)


vs ASX 200 (1yr)


$84.67 million

Market Cap

Share Issue

78.04 million

All Ords (%)


Short Sold


Current Fundamentals

23 January


PE Ratio

EPS ($)


Earnings Yield


NTA ($)



Dividend Yield

DPS ($)


Gross Div. Yield


Gross DPS ($)


Company Overview

Imricor Medical Systems Inc (IMR) is a US based medical device company that seeks to address the current issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The Company's primary product offering, the Vision-MR Ablation Catheter is specifically designed to work under real-time MRI guidance, with the intent of enabling higher success rates along with a faster and safer treatment compared to conventional procedures using x-ray guided catheters.

Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB Logo

Corporate Details

Head Office: Burnsville Minnesot
Managing Director: Steve Wedan
GICS Sub-Industry: Health Care Equipment
Date Listed: 30 Aug 2019
Registry: -
Similar Companies: RMD / COH / FPH / ANN / NAN

Upcoming Calendar

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.


Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

IMR is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data

Name Title Since Bio
Mr Peter McGregor Non-Executive Director May 2019
Ms Doris Engibous Non-Executive Director Apr 2019
Mr Steve Wedan Chief Executive Officer, President, Executive Chairman, Executive Director May 2006
Mr Mark Tibbles Non-Executive Director Sep 2014

Director Transactions

About the Data

IMR directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
31/12/19 Steve Wedan Issued 501 $1.194 $598 Conversion of convertible notes.
31/12/19 Steve Wedan Transfer 2,518,219 $1.195 $3,009,271 Off-market transfer.
31/12/19 Mark Tibbles Issued 2,897 $1.195 $3,461 Conversion of convertible notes.
24/12/19 Mark Tibbles Exercise 30,000 $0.341 $10,230 Exercise of options.
24/12/19 Mark Tibbles Buy +30,000 $0.341 $10,230 Exercise of options.

Shareholder Distribution

Shareholder Distribution data is unavailable.

Top 20 Shareholders

About the Data

Name Shares Capital
Siemens Medical Solutions USA 8,761,342 9.43%
Warren G Herreid II 7,680,486 8.26%
Mark A Tibbles 4,548,981 4.89%
J P Morgan Nominees Australia Pty Limited 3,820,819 4.11%
Khar Foundation 2,814,002 3.03%
National Nominees Limited 2,740,963 2.95%
Merrill Lynch (Australia) Nominees Pty Ltd 2,680,573 2.88%
Steven R Wedan 2,518,219 2.71%
Albert C Lardo & Jennifer S Lardo 2,400,000 2.58%
Bauer Private Equity Fund VI 1,696,555 1.83%
Merrill Lynch (Australia) Nominees Pty Limited 1,691,229 1.82%
Steven R Wedan & Cherri J Wedan JT Ten 1,427,373 1.54%
Pensco Trust Company Llc (i) 1,187,289 1.28%
Ramsey & Co 1,057,349 1.14%
James Dobchuk 967,004 1.04%
HSBC Custody Nominees (Australia) Limited 963,695 1.04%
NF Technology Holdings Ag 959,800 1.03%
Fleitman Koppa Investments Llc 901,530 0.97%
Pensco Trust Company Llc (ii) 865,876 0.93%
Pershing Australia Nominees Pty Ltd 829,472 0.89%
All other shareholders 45.65 %

The Top 20 Shareholders of IMR hold 54.35% of shares on issue.

IMR Share Price History

Date Close Change % Change Open High Low Volume Turnover

IMR Historical Data

Download up to 20 years of share price history.

Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Development of MRI-compatible medical devices to carry out MRI-guided cardiac catheter ablation procedures.

Incorporated: --

400 Gateway Bvd
Burnsville Minnesot USA 55337

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.